Bailard’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $657K | Sell |
8,400
-256
| -3% | -$20K | 0.02% | 422 |
|
|
2025
Q1 | $627K | Buy |
8,656
+660
| +8% | +$47.8K | 0.02% | 413 |
|
|
2024
Q4 | $592K | Sell |
7,996
-31,187
| -80% | -$2.31M | 0.02% | 428 |
|
|
2024
Q3 | $2.59M | Sell |
39,183
-16,043
| -29% | -$1.06M | 0.07% | 205 |
|
|
2024
Q2 | $5.1M | Sell |
55,226
-530
| -1% | -$49K | 0.14% | 136 |
|
|
2024
Q1 | $5.33M | Buy |
55,756
+6,343
| +13% | +$606K | 0.15% | 138 |
|
|
2023
Q4 | $3.77M | Sell |
49,413
-7,218
| -13% | -$550K | 0.11% | 163 |
|
|
2023
Q3 | $3.92M | Buy |
56,631
+789
| +1% | +$54.7K | 0.13% | 141 |
|
|
2023
Q2 | $5.27M | Sell |
55,842
-12,750
| -19% | -$1.2M | 0.18% | 109 |
|
|
2023
Q1 | $5.67M | Sell |
68,592
-360
| -0.5% | -$29.8K | 0.2% | 107 |
|
|
2022
Q4 | $5.14M | Sell |
68,952
-1,215
| -2% | -$90.7K | 0.2% | 106 |
|
|
2022
Q3 | $5.8M | Buy |
70,167
+682
| +1% | +$56.4K | 0.24% | 95 |
|
|
2022
Q2 | $6.61M | Buy |
69,485
+288
| +0.4% | +$27.4K | 0.26% | 85 |
|
|
2022
Q1 | $8.15M | Buy |
69,197
+2,855
| +4% | +$336K | 0.27% | 85 |
|
|
2021
Q4 | $8.6M | Sell |
66,342
-2,166
| -3% | -$281K | 0.27% | 85 |
|
|
2021
Q3 | $7.76M | Sell |
68,508
-294
| -0.4% | -$33.3K | 0.27% | 90 |
|
|
2021
Q2 | $7.13M | Sell |
68,802
-77
| -0.1% | -$7.98K | 0.25% | 95 |
|
|
2021
Q1 | $5.76M | Buy |
+68,879
| New | +$5.76M | 0.21% | 102 |
|
|
2020
Q3 | – | Sell |
-2,944
| Closed | -$203K | – | 584 |
|
|
2020
Q2 | $203K | Buy |
+2,944
| New | +$203K | 0.01% | 435 |
|
|
2019
Q4 | – | Sell |
-2,901
| Closed | -$213K | – | 552 |
|
|
2019
Q3 | $213K | Buy |
+2,901
| New | +$213K | 0.01% | 462 |
|